CROs working on Cell Therapy
Cell Therapy is an important modality used by sponsors to shortlist partners for specific delivery, regulatory, and execution needs. This page groups CRO organizations working on Cell Therapy, so you can quickly identify which teams align with your program priorities without having to scan unrelated profiles.
Use this listing as a starting point: open each profile to review scope, facility footprint, and public evidence that supports the listed capabilities. Because the directory is fit-first, the goal is not to crown one universal "best" provider, but to help you build a right-sized shortlist for your stage, geography, and quality expectations.
When you are ready to compare options, move to search and add filters for adjacent criteria such as modalities, indications, and claim status. Combining this modality view with those filters makes it easier to narrow quickly from discovery to outreach while keeping the process transparent and reproducible.
Auto-generated by BioBM Editorial AI.
Matching companies
- Accelevir
CLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs.
- Accelsiors
Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design.
- Allucent
Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies.
- Altasciences
Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- Aragen Life Sciences
Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- Caidya
Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research.
- Cellentia, Inc.
Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.
- Certara
Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- Champions Oncology
Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services.
- Charles River Laboratories
Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
- Clinical Research Network India Pvt. Ltd.
Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices.
- Creative Bioarray
Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.
- Crown Bioscience
Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
- Cyagen Biosciences
Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.
- Cyagen Biosciences
Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
- Ergomed Clinical Research
Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
- Esco Aster
Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.
- Fortrea
Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
- Frontage Laboratories
Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
- GenoSafe
GenoSafe is an analytical CRO for gene and cell therapies, innovative vaccines and DNA/RNA-based products. It offers preclinical analytical testing, quality control method development for ATMPs, and clinical sample bioanalysis.
- ICON plc
ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
- IPM Biotech
IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine.
- IQVIA
IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.
- Inotiv
Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.
- JangoCell
JangoCell provides contract cell expansion, flow cytometry, cell sorting, and molecular biology services for researchers, with expertise in both 2D and 3D bioreactor-based culture systems scaling to billions of cells.
- KCAS Bio
Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.
- LIDE Biotech
Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
- Labcorp
Labcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
- Medpace
Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
- Noble Life Sciences
Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.
- Novotech
Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.
- PPD
PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
- Parexel
Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.
- Pharmaron
Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- Premier Research
Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- PrimeVigilance
Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
- ProBio
ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
- Proone Labs
Proone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
- Protheragen
Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
- QPS
QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
- Reaction Biology
Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
- SGVector
SGVector develops and manufactures viral vectors for cell and gene therapies, offering vector design, process development, scale-up, and analytical testing services with a scalable suspension-based platform.
- STEMCELL Technologies Inc.
STEMCELL Technologies develops and sells cell culture media, cell separation systems, instruments, and reagents for life sciences research, plus contract research services including biopharmaceutical testing, cell characterization, toxicity testing, and organoid assays.
- Solvias
Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.
- StemExpress
StemExpress, now part of CGT Global, supplies biospecimens and cell processing services for research and clinical applications, including GMP-grade leukopaks, PBMCs, and custom cell isolations.
- Syneos Health
Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
- Syngene International
Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- TATAA Biocenter
GLP- and GCLP-compliant molecular CRO specializing in bioanalysis for gene therapy, RNA therapeutics, and advanced modalities, offering qPCR, NGS, and plasma proteomics services since 2001.
- Tigermed
Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
- Worldwide Clinical Trials
Full-service global CRO with 30+ years of therapeutic expertise, delivering personalized clinical trial support across rare disease, cardiovascular, cell & gene therapy, oncology, and neuroscience.
Markdown mirror: /modalities/mod_cell_therapy.md